Company Description
ALK-Abelló is a leading producer of allergy vaccination pharmaceuticals. The company is the result of the merger of ALK-Abelló and the...
Key ALK-Abelló Financials
| Company Type | Public - Copenhagen: ALK-B Main Headquarters |
|---|---|
| Fiscal Year-End | August |
| 2006 Employees | 1,266 |
More ALK-Abelló Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about ALK-Abelló's competition across multiple industries
Top ALK-Abelló Competitors
Sponsored Links
The Business DirectoryALK-Abelló Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Jřrgen Worning | Network | E-mail |
| President and CEO | Jens Bager | Network | E-mail |
| VP CFO, Finance, and IT | Jutta af Rosenburg | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current ALK-Abelló News
- A CONTAINER FOR A BLISTER PACKAGE [European Patents] (15 Oct 2008 10:18:00 EDT)
- Use of an adjuvanted allergy vaccine formulation for parenteral administration [European Patents] (15 Oct 2008 10:14:00 EDT)
- Use of an adjuvanted allergy vaccine formulation for parenteral administration [European Patents] (15 Oct 2008 10:14:00 EDT)
Sponsored Opportunity





